glutathione polyol pathway Development of atherosclerosis via ROS production in the Diabetes-induced polyol pathway, leading to
Description
Kadian et al., 2022)
Rui J, Deng S, Arazi A, Perdigoto AL, Liu Z, Herold KC
Dhanjal D
However, the ZEA metabolites exhibited lower toxicity than ZEA, with zearalenol being the more active of the two metabolites [125]
Targeting improvement through surface modification : Nanoparticles have the ability to functionalize their surface with tumour specific ligand or peptides to markedly improve targeting
